Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain

Drug Design, Development and Therapy

Volumn 7, Issue , 2013, Pages 7-12

  Palmieri, Beniamino ^a,b   Rottigni, Valentina ^a,b   Iannitti, Tommaso ^b,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Poliambulatorio del Secondo Parere   (Italy)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Bisphosphonate; Combination therapy; Diclofenac sodium; Hyaluronic acid; Knee; Nonsteroidal anti inflammatory drug; Osteoarthritis; Pain; Sodium clodronate; Viscosupplementation

Indexed keywords

C REACTIVE PROTEIN; CLODRONIC ACID; DICLOFENAC; HYALURONIC ACID; INFORCE; UNCLASSIFIED DRUG; VARIOFILL;

ADULT; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE PAIN; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN BRUISING; VISUAL ANALOG SCALE;

BISPHOSPHONATE; COMBINATION THERAPY; DICLOFENAC SODIUM; HYALURONIC ACID; KNEE; NONSTEROIDAL ANTI-INFLAMMATORY DRUG; OSTEOARTHRITIS; PAIN; SODIUM CLODRONATE; VISCOSUPPLEMENTATION;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CLODRONIC ACID; CROSS-LINKING REAGENTS; DICLOFENAC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 84872310114     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S37330     Document Type: Article

References (19)

1. Iannitti T, Lodi D, Palmieri B. Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid. Drugs R D. 2011;11(1):13-27.
2. Garcia-Fuentes M, Meinel AJ, Hilbe M, Meinel L, Merkle H P. Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials. 2009;30(28): 5068-5076.
3. Kim SB, Kwon DR, Kwak H, et al. Additive effects of intra-articular injection of growth hormone and hyaluronic acid in rabbit model of collagenase-induced osteoarthritis. J Korean Med Sci. 2010;25(5): 776-780.
4. Elron-Gross I, Glucksam Y, Margalit R. Liposomal dexamethasone- diclofenac combinations for local osteoarthritis treatment. Int J Pharm. 2009;376(1-2):84-91.
5. Lima Gda S, Silva GF, Gomes A P, de Araujo LM, Salum FG. Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis. J Appl Oral Sci. 2010;18(5):533-537.
6. Maltusch A, Rowert-Huber J, Matthies C, Lange-Asschenfeldt S, Stockfleth E. Modes of action of diclofenac 3%/hyaluronic acid 2.5% in the treatment of actinic keratosis. J Dtsch Dermatol Ges. 2011;9(12):1011-1017.
7. Cocco R, Tof C, Fioravanti A, et al. Effects of clodronate on synovial fuid levels of some inflammatory mediators, after intra-articular administration to patients with synovitis secondary to knee osteoarthritis. Boll Soc Ital Biol Sper. 1999;75(11-12):71-76.
8. Rossini M, Viapiana O, Ramonda R, et al. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rheumatology. 2009;48(7):773-778.
9. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494-502.
10. Ogston AG, Stanier JE. The physiological function of hyaluronic acid in synovial fuid; viscous, elastic and lubricant properties. J Physiol. 1953;119(2-3):244-252.
11. Swann DA, Radin EL, Nazimiec M, Weisser PA, Curran N, Lewinnek G. Role of hyaluronic acid in joint lubrication. Ann Rheum Dis. 1974;33(4):318-326.
12. Homandberg GA, Ummadi V, Kang H. Hyaluronan enhances cartilage repair through low grade tissue remodeling involving cytokines and matrix metalloproteinases. Infamm Res. 2004;53(10):534-543.
13. Ialenti A, Di Rosa M. Hyaluronic acid modulates acute and chronic infammation. Agents Actions. 1994;43(1-2):44-47.
14. Foglar C, Lindsey RW. C-reactive protein in orthopedics. Orthopedics. 1998;21(6):687-691.
15. Turan Y, Bal S, Gurgan A, Topac H, Koseoglu M. Serum hyaluronan levels in patients with knee osteoarthritis. Clin Rheumatol. 2007; 26(8):1293-1298.
16. van Leeuwen MA, van Rijswijk MH. Acute phase proteins in the monitoring of inflammatory disorders. Baillieres Clin Rheumatol. 1994;8(3):531-552.
17. Tarik MH, David HK. C-reactive protein and erythrocyte sedimentation rate in orthopaedics. The University of Pennsylvania Orthopaedic Journal. 2002;15:13-16.
18. Ng T. Erythrocyte sedimentation rate, plasma viscosity and C-reactive protein in clinical practice. Br J Hosp Med. 1997;58(10):521-523.
19. Iannitti T, Rosini S, Lodi D, Frediani B, Rottigni V, Palmieri B. Bisphosphonates: focus on infammation and bone loss. Am J Ther. 2012;19(3):228-246.